Evidence map›Paper›PMID 38523879›Full record

ArticleCurrent opinion in physiology2023

Regulation, Maintenance, and Remodeling of High Endothelial Venules in Homeostasis, Inflammation, and Cancer.

Nancy H Ruddle

Open access · hybridAbstract read
In one paragraph

Article in Current opinion in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. The theory of the inflammatory ecosystem.Science China. Life sciences · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Nancy H RuddleEpidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520-8034.
Yale University · US

Funding

LYMPHOTOXIN AND LYMPHOID NEOGENESISR01DK057731 · NIDDK · YALE UNIVERSITY · PI RUDDLE, NANCY H. · 2000 to 2010
$3.0M
TNF BETA--REGULATION AND BIOLOGIC SIGNIFICANCER01CA016885 · NCI · YALE UNIVERSITY · PI RUDDLE, NANCY H. · 1985 to 2006
$2.0M
NCI NIH HHS R01 CA016885NIDDK NIH HHS R01 DK057731
6 · The paper itself

Abstract

High endothelial venules (HEVs), high walled cuboidal blood vessels, through their expression of adhesion molecules and chemokines, allow the entrance of lymphoid cells into primary, secondary, and tertiary lymphoid structures (aka tertiary lymphoid organs). HEV heterogeneity exists between various lymphoid organs in their expression of peripheral node addressin (PNAd) and mucosal vascular addressin adhesion molecule 1(MAdCAM-1). Transcriptomic analyses reveal extensive heterogeneity, plasticity, and regulation of HEV gene expression in ontogeny, acute inflammation, and chronic inflammation within and between lymphoid organs. Rules regulating HEV development are flexible in inflammation. HEVs in tumor tertiary lymphoid structures are diagnostic of favorable clinical outcome and response to Immunotherapy, including immune check point blockade. Immunotherapy induces HEVs and provides an entrance for naïve, central memory, and effector cells and a niche for stem like precursor cells. Understanding HEV regulation will permit their exploitation as routes for drug delivery to autoimmune lesions, rejecting organs, and tumors.

Indexed as

CancerHigh endothelial venuleImmune check point blockadeInflammationLymph nodeMucosal addressin cellular adhesion molecule (MAdCAM-1)Peripheral node addressin (PNAd)Tertiary lymphoid organTertiary lymphoid structureTranscriptomicsTumor

Identifiers

PMID38523879
PMCPMC10956444
OpenAlexW4385988988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.